secwatch.observer — SEC 8-K summary
======================================

Issuer:     GILEAD SCIENCES, INC. (GILD)
CIK:        0000882095
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0000882095-26-000008
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead shareholders elect all nine directors, approve equity plan increase, reject three proposals
--------------------------------------------------------------------------------

- All nine director nominees elected; Daniel O'Day received 980.6M votes for, 50.2M against.
- Ernst & Young ratified as auditor for FY 2026: 1,046.4M for, 82.8M against, 1.0M abstain.
- Say-on-pay approved with 954.3M for (92.6% of votes cast excluding broker non-votes).
- Amended 2022 Equity Incentive Plan approved, adding 47.75M new shares to the pool.
- Shareholder proposals on independent chair, patent exclusivity, and ESG metrics all defeated by wide margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/0000882095-26-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/gild-20260430.htm
  HTML page:      https://secwatch.observer/filing/0000882095-26-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer